Direkt zum Inhalt
Merck
  • Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.

Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking.

Nature communications (2021-08-13)
Lin-Ping Wu, Mario Ficker, Jørn B Christensen, Dmitri Simberg, Panagiotis N Trohopoulos, Seyed M Moghimi
ZUSAMMENFASSUNG

Complement is an enzymatic humoral pattern-recognition defence system of the body. Non-specific deposition of blood biomolecules on nanomedicines triggers complement activation through the alternative pathway, but complement-triggering mechanisms of nanomaterials with dimensions comparable to or smaller than many globular blood proteins are unknown. Here we study this using a library of <6 nm poly(amido amine) dendrimers bearing different end-terminal functional groups. Dendrimers are not sensed by C1q and mannan-binding lectin, and hence do not trigger complement activation through these pattern-recognition molecules. While, pyrrolidone- and carboxylic acid-terminated dendrimers fully evade complement response, and independent of factor H modulation, binding of amine-terminated dendrimers to a subset of natural IgM glycoforms triggers complement activation through lectin pathway-IgM axis. These findings contribute to mechanistic understanding of complement surveillance of dendrimeric materials, and provide opportunities for dendrimer-driven engineering of complement-safe nanomedicines and medical devices.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Albumin aus Humanserum, lyophilized powder, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
Zymosan A aus Saccharomyces cerevisiae, for inducing inflamatory response
Sigma-Aldrich
Anti-Maus-IgG-Antikörper der Ziege, (H+L) HRP Konjugat, 1 mg/mL, Chemicon®
HiTrap® Protein G High Performance, Cytiva 17-0404-01, pack of 5 × 1 mL